pubmed.ncbi.nlm.nih.gov

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression - PubMed

Randomized Controlled Trial

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression

Alexander S Korb et al. Clin Neurophysiol. 2009 Jul.

Abstract

Objective: To assess whether pretreatment theta current density in the rostral anterior cingulate (rACC) and medial orbitofrontal cortex (mOFC) differentiates responders from non-responders to antidepressant medication or placebo in a double-blinded study.

Methods: Pretreatment EEGs were collected from 72 subjects with Major Depressive Disorder (MDD) who participated in one of three placebo-controlled trials. Subjects were randomized to receive treatment with fluoxetine, venlafaxine, or placebo. Low-resolution brain electromagnetic tomography (LORETA) was used to assess theta current density in the rACC and mOFC.

Results: Medication responders showed elevated rACC and mOFC theta current density compared to medication non-responders (rACC: p=0.042; mOFC: p=0.039). There was no significant difference in either brain region between placebo responders and placebo non-responders.

Conclusions: Theta current density in the rACC and mOFC may be useful as a biomarker for prediction of response to antidepressant medication.

Significance: This is the first double-blinded treatment study to examine pretreatment rACC and mOFC theta current density in relation to antidepressant response and placebo response. Results support the potential clinical utility of this approach for predicting clinical outcome to antidepressant treatments in MDD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Regions of Interest

A sagittal view of the ROIs used in our analyses. A) rACC. B) mOFC

Figure 2
Figure 2. Relative Surface Power

Relative surface theta power superimposed on the brain for A) Responders and B) Non-responders.

Figure 3
Figure 3. Theta Current Density

— indicates mean. Medication group theta current density separated by response in A) rACC, B) mOFC, and C) PCC. Placebo group theta current density separated by response in D) rACC, E) mOFC, and F) PCC.

Similar articles

Cited by

References

    1. Asada H, Fukuda Y, Tsunoda S, Yamaguchi M, Tonoike M. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett. 1999;274:29–32. - PubMed
    1. Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Hoschl C. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res. 2007;41:319–25. - PubMed
    1. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27:120–31. - PubMed
    1. First MB, Spitzer RL, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders. Patient Edition. New York State Psychiatric Institute, Biometrics Research Department; New York: 1995. (SCID-I/P, version 2.0)
    1. Gloor P. Neuronal generators and the problem of localization in electroencephalography: application of volume conductor theory to electroencephalography. J Clin Neurophysiol. 1985;2:327–54. - PubMed

Publication types

MeSH terms

Substances